BOLT - Bolt Biotherapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BOLT is currently covered by 3 analysts with an average price target of $2.84. This is a potential upside of $-2.96 (-51.03%) from yesterday's end of day stock price of $5.8.

Bolt Biotherapeutics's activity chart (see below) currently has 11 price targets and 17 ratings on display. The stock rating distribution of BOLT is 66.67% HOLD and 33.33% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 46.67% with an average time for these price targets to be met of 306.17 days.

Highest price target for BOLT is $4, Lowest price target is $4, average price target is $4.

Most recent stock forecast was given by CHAD MESSER from LAKE STREET on 14-Aug-2025. First documented stock forecast 02-Mar-2021.

Best performing analysts who are covering BOLT - Bolt Biotherapeutics:

Stephen Willey Edward White Daina Graybosch Matthew Harrison Michael Schmidt Chad Messer

Currently out of the existing stock ratings of BOLT, 4 are a HOLD (66.67%), 2 are a BUY (33.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$4

$-1.8 (-31.03%)

$4

1 months 28 days ago
(14-Aug-2025)

0/2 (0%)

$-1.15 (-22.33%)

Hold

5 months ago
(12-May-2025)

3/3 (100%)

$-10.6 (-63.86%)

627

Hold

6 months 18 days ago
(24-Mar-2025)

6/6 (100%)

$-18 (-69.23%)

662

Hold

$1

$-4.42 (-81.55%)

$4

1 years 4 months 27 days ago
(15-May-2024)

4/5 (80%)

$0.17 (20.48%)

548

Hold

$42

1 years 4 months 27 days ago
(15-May-2024)

0/1 (0%)

$10.34 (32.66%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BOLT (Bolt Biotherapeutics) average time for price targets to be met?

On average it took 306.17 days on average for the stock forecasts to be realized with a an average price target met ratio 46.67

Which analyst has the current highest performing score on BOLT (Bolt Biotherapeutics) with a proven track record?

STEPHEN WILLEY

Which analyst has the current lower performing score on BOLT (Bolt Biotherapeutics) with a proven track record?

CHAD MESSER

Which analyst has the most public recommendations on BOLT (Bolt Biotherapeutics)?

Stephen Willey works at STIFEL and has 12 price targets and 8 ratings on BOLT

Which analyst is the currently most bullish on BOLT (Bolt Biotherapeutics)?

Matthew Harrison with highest potential upside - $1.68

Which analyst is the currently most reserved on BOLT (Bolt Biotherapeutics)?

Daina Graybosch with lowest potential downside - -$4.42

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?